Myasthenia gravis

Myasthenia gravis financial assistance for insurance premiums

PAN Foundation

Patients must be receiving treatment for myasthenia gravis with a covered medication and reside in the United States or its territories. Eligible applicants must also have government-insured health coverage and a household income at or below 500% of the Federal Poverty Level.

Access and Co-pay Assistance - VYVGART Hytrulo

Eligible patients must have commercial insurance and a valid prescription for an on-label indication of VYVGART or VYVGART Hytrulo. The program provides up to $25,000 per calendar year to cover out-of-pocket drug and administration costs.

PAN Foundation Myasthenia Gravis medication copay financial assistance

PAN Foundation

Applicants must be receiving treatment for myasthenia gravis in the United States, possess government-insured health coverage, and have an income at or below 500% of the Federal Poverty Level. The grant covers out-of-pocket costs for a specific list of prescribed medications up to an annual limit.

Assistance Fund: Myasthenia Gravis - Requirements & Forms

Applicants must be U.S. citizens or permanent residents diagnosed with Myasthenia Gravis and residing in the U.S. or Puerto Rico. This needs-based program requires enrollment and coverage by commercial, Medicare, or Medicaid insurance.

Myasthenia Gravis Financial Assistance Program

The Assistance Fund

Applicants must be U.S. citizens or permanent residents diagnosed with Myasthenia Gravis and prescribed an FDA-approved treatment. Candidates must also have prescription coverage and meet financial eligibility criteria based on household income and size.

VYVGART Co-pay Program

Patients must have a valid prescription for VYVGART Hytrulo and coverage through a private or commercial insurance plan. Individuals with government-funded insurance (e.g., Medicare, Medicaid) or those who are uninsured are not eligible.